Amneal Pharmaceuticals, Inc. (AMRX) forecast

Amneal Pharmaceuticals, Inc. (AMRX) forecast: price $20.39, trailing P/E 40.60, forward P/E 19.92. How to read the street's path.

$20.39Price
$6.51BMarket cap
40.60P/E ?
19.92Forward P/E ?
0.00%Dividend yield ?

The live AMRX price is $20.39. Trailing P/E is 40.60 and forward P/E is 19.92. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the AMRX forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full AMRX quote · Dividends · Price prediction · Academy

Questions

What is AMRX's forward P/E?

The latest forward P/E on Stocklytics is 19.92, against a trailing P/E of 40.60 and a price of $20.39.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.